COMP <GO>
LNTH vs ORKA // RETURN ON INVESTED CAPITAL (ROIC)
Lantheus Holdings Inc. (NASDAQ) VS. Oruka Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: LNTH 8
— ORKA 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LNTH
LAST: $100.31 (-0.15%) • MKT CAP: $6.56B
roic
20.30%
LAST: $95.43 (-1.49%) • MKT CAP: $6.41B
roic
-18.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. ORKA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNTH | ORKA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 20.30% | -18.80% | +39.10 | LNTH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | -1.38% | +6.28 | LNTH | /fcf-yield <GO> |
| Operating Margin | 20.20% | -6.80% | +27.00 | LNTH | /operating-margins <GO> |
| Net Profit Margin | 15.20% | -5.90% | +21.10 | LNTH | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | -4.40% | +4.90 | LNTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.34 | 26.00 | -20.66 | ORKA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | LNTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.8 | 67.0 | -11.20 | ORKA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.13 | -0.25 | ORKA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 28.0x | -2.00 | LNTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.56B | $6.41B | $143.5M | LNTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNTH REV | ORKA REV | LNTH GROSS % | ORKA GROSS % | LNTH FCF | ORKA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.54B | $341.7M | 61.1% | — | $320.8M | -$88.4M |
| FY 2024 | $1.53B | $246.7M | 64.4% | — | $475.7M | -$58.0M |
| FY 2023 | $1.30B | $20.4M | — | — | $246.9M | -$5.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
ORKA // BETA 1.13